Tapered Conduit Encapsulation for Islet Transplantation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current encapsulated pancreatic islet transplantation methods for diabetes management face challenges in providing adequate immunoprotection and insulin release, with existing capsular designs either compromising immunoprotection or mass transport, leading to insufficient glucose control and insulin delivery.
Innovation Solution
A semi-permeable capsular membrane with tapered conduits, comprising multiple layers with increasing pore sizes from the immunoprotection layer to the backbone layer, designed to enhance insulin release while maintaining immunoprotection, achieved by using similar polymer compositions with varying concentrations to form a stable membrane with larger pore sizes internally and smaller pore sizes externally.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a thin semi-permeable membrane with uniform pores is used, then mass transport of insulin is improved, but immunoprotection is compromised
Solution Approach 1:
The membrane is divided into multiple layers with different pore size distributions. The outer layer has smaller pores for immunoprotection, while inner layers have progressively larger pores for improved insulin transport, creating segmented functional zones within the membrane structure
Solution Approach 2:
Different regions of the membrane have different pore size characteristics tailored to their specific functions. The outer surface has smaller pores to block immune cells, while the inner regions have larger pores to facilitate insulin efflux, creating local quality variations that optimize both protection and transport
2Reliability
If a thick membrane with small pores is used, then immunoprotection is improved, but mass transport of insulin is compromised
Solution Approach 1:
The thick membrane is segmented into multiple functional layers, with the outer layers providing immunoprotection through small pores and the inner layers providing transport pathways through larger pores, allowing the thick membrane to simultaneously achieve both protection and transport functions
Solution Approach 2:
The solution moves from a single uniform pore size to a multi-dimensional pore size distribution across the membrane thickness. By varying pore size in the depth dimension rather than using a single pore size, the membrane achieves both immunoprotection and efficient mass transport
3Ease of manufacture
If uniform pore size is used throughout the membrane, then manufacturing simplicity is maintained, but both immunoprotection and insulin release are compromised
Solution Approach 1:
The membrane fabrication process is segmented into multiple stages, with each stage creating a layer with specific pore size characteristics. This segmented approach allows control over pore size distribution while maintaining a systematic manufacturing process
Solution Approach 2:
The manufacturing process controls pore size by changing parameters such as polymer concentration, crosslinking density, or processing conditions across different membrane layers, creating a gradient pore size distribution that optimizes both protection and transport functions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The tapered conduit design improves mass transport and insulin release, maintaining effective immunoprotection and extending the functional longevity of transplanted islets, potentially offering a functional cure for diabetes without the need for immunosuppressive drugs.
Implementation Method 1
a thin (about 0.5 μm) semi-permeable islet encapsulation membrane
Implementation Method 2
The Barrier Model has a thick membrane of about 25 μm with a pore size distribution cutoff (about 90% of pores are smaller than the cutoff) of about 20 nm in diameter. It allows small molecules, such as nutrients and oxygen to enter the membrane with ease.
Implementation Method 3
The capsular membrane pore size distribution (PSD) was obtained from the measurements of solute size exclusion coefficients (KSEC) with known size of solute molecules.
Data Source
AI summary
Some embodiments of the present disclosure include an encapsulated islet for treating diabetes. The encapsulated islet may include a semi-permeable capsular membrane having a plurality of layers including an outer immunoprotection layer, a bridging layer, and an inner backbone layer. A continuous fluid-flow manufacturing process may start production of all membrane layers simultaneously, but at different growth rates for different layers. Each layer may have a plurality of pores, wherein the pores increase in size from the immunoprotection layer to the backbone layer, creating the tapered conduits. The semi-permeable capsular membrane may include the following layers, in order from outermost layer to innermost layer: an immunoprotection layer, a bridging layer, and a backbone layer. With proper balancing of membrane thickness and tapered pore size distribution, the encapsulated islets may be configured to offer a improve insulin transport and offer diabetes patients a treatment or functional cure without immunosuppressive drugs.